<abstract xmlns="http://www.w3.org/1999/xhtml"> Background: Breast cancer is the most common cancer in women. To study factors causing breast cancer, various epidemiological and experimental studies are being conducted. A relation may exist between vitamin D, folic acid, testosterone, and various neoplasms.Objectives: Detect the levels of vitamin D, folic acid, and testosterone in breast cancer of patients and healthy subjects, and determine the relation of the levels of vitamin D, folic acid, and testosterone with tumor histopathology, stage, and receptor status.Methods: Eighty patients diagnosed with breast cancer and 20 controls (healthy volunteers) were enrolled in the study. Serum samples were collected from the patients and the controls, and examined using Roche E-170 with its own special kit.Results: Folic acid levels were higher in the patient group and the difference was statistically significant (p=0.044). The levels of testosterone were lower in post-menopausal patients (p=0 .018). In stage I-II (early-stage) patients, vitamin D levels were higher, while in the stage III-IV (advanced-stage) patients, the levels were lower (p=0.048).Conclusions: Low vitamin D levels may be related to poor prognosis. Low levels of folic acid were detected in the control group. Low levels of folic acid but high vitamin D and testosterone levels may be protective against breast cancer.</abstract>

Background: Breast cancer is the most common cancer in women. To study factors causing breast cancer, various epidemiological and experimental studies are being conducted. A relation may exist between vitamin D, folic acid, testosterone, and various neoplasms.Objectives: Detect the levels of vitamin D, folic acid, and testosterone in breast cancer of patients and healthy subjects, and determine the relation of the levels of vitamin D, folic acid, and testosterone with tumor histopathology, stage, and receptor status.Methods: Eighty patients diagnosed with breast cancer and 20 controls (healthy volunteers) were enrolled in the study. Serum samples were collected from the patients and the controls, and examined using Roche E-170 with its own special kit.Results: Folic acid levels were higher in the patient group and the difference was statistically significant (p=0.044). The levels of testosterone were lower in post-menopausal patients (p=0 .018). In stage I-II (early-stage) patients, vitamin D levels were higher, while in the stage III-IV (advanced-stage) patients, the levels were lower (p=0.048).Conclusions: Low vitamin D levels may be related to poor prognosis. Low levels of folic acid were detected in the control group. Low levels of folic acid but high vitamin D and testosterone levels may be protective against breast cancer.

Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study

Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080,

MD, Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080,

Department of Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080,

Asian Biomedicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Background: Breast cancer is the most common cancer in women. To study factors causing breast cancer, various epidemiological and experimental studies are...

Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study

Article Category: Brief communication (Original)

Pubblicato online: 04 feb 2017

Pagine: 663 - 667

DOI: https://doi.org/10.5372/1905-7415.0505.097

Parole chiave
Breast neoplasms, folic acid, serum, testosterone, vitamin D

© 2017

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study

Article Category: Brief communication (Original)

Pubblicato online: 04 feb 2017

Pagine: 663 - 667

DOI: https://doi.org/10.5372/1905-7415.0505.097

Parole chiaveBreast neoplasms, folic acid, serum, testosterone, vitamin D

© 2017

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Parole chiave
Breast neoplasms, folic acid, serum, testosterone, vitamin D